BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18220562)

  • 1. The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.
    Liu X; Jia L
    Curr Drug Metab; 2007 Dec; 8(8):815-21. PubMed ID: 18220562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conduct of drug metabolism studies considered good practice (II): in vitro experiments.
    Jia L; Liu X
    Curr Drug Metab; 2007 Dec; 8(8):822-9. PubMed ID: 18220563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
    Nassar AE; Adams PE
    Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdosing assessment to evaluate pharmacokinetics and drug metabolism in rats using liquid chromatography-tandem mass spectrometry.
    Ni J; Ouyang H; Aiello M; Seto C; Borbridge L; Sakuma T; Ellis R; Welty D; Acheampong A
    Pharm Res; 2008 Jul; 25(7):1572-82. PubMed ID: 18299965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology.
    Kamel A; Prakash C
    Curr Drug Metab; 2006 Dec; 7(8):837-52. PubMed ID: 17168686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nano-electrospray for metabolite identification and quantitative absorption, distribution, metabolism and excretion studies.
    Hop CE
    Curr Drug Metab; 2006 Jun; 7(5):557-63. PubMed ID: 16787163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical tools and approaches for metabolite identification in early drug discovery.
    Chen Y; Monshouwer M; Fitch WL
    Pharm Res; 2007 Feb; 24(2):248-57. PubMed ID: 17048114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.
    Grangeon A; Gravel S; Gaudette F; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():144-158. PubMed ID: 27978469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of mass spectrometry for metabolite identification.
    Ma S; Chowdhury SK; Alton KB
    Curr Drug Metab; 2006 Jun; 7(5):503-23. PubMed ID: 16787159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New analytical strategies in studying drug metabolism.
    Staack RF; Hopfgartner G
    Anal Bioanal Chem; 2007 Aug; 388(7):1365-80. PubMed ID: 17583803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the "Metabolites in Safety Testing" Regulatory Guidance.
    Schadt S; Bister B; Chowdhury SK; Funk C; Hop CECA; Humphreys WG; Igarashi F; James AD; Kagan M; Khojasteh SC; Nedderman ANR; Prakash C; Runge F; Scheible H; Spracklin DK; Swart P; Tse S; Yuan J; Obach RS
    Drug Metab Dispos; 2018 Jun; 46(6):865-878. PubMed ID: 29487142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
    Baumann A; Karst U
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.